Antiphospholipids Antibodies and Migraine
Sahel medical journal (Print)
; 12(2)2009.
Article
in English
| AIM
| ID: biblio-1271566
Responsible library:
CG1.1
ABSTRACT
Background:
Antiphospholipids antibodies has been associated with non-thrombotic neurological conditions such as migraine. We set out to estimate the concentration of antiphospholipids antibody among patients with migraine and normal population.Methods:
This is prospective case-control study of 158 subjects including 82 migraine patients who fulfilled the International Headache Society criteria for the diagnosis of migraine headache and 76 age and sex-matched controls who were mostly hospital staff and medical students. Blood samples were taken for quantification of antiphospholipids antibodies.Results:
There were 28 males and 54 females among the migraine patients and 30 males and 46 females among the controls. Their mean ages were 28.8 + 8.4 years and 26.4 + 3.9 years; respectively. Migraine patients had increased level of aPL (lgG anti Beta2GP1) 27.76 + 14.47IU/ml compared to the normal healthy adults (21.43 + 9.4IU/ml) (p0.05). Similarly; antiphospholipid antibodies was significantly elevated in migraine patients with aura compared to those without aura; (?2
Search on Google
Index:
AIM (Africa)
Main subject:
Case-Control Studies
/
Migraine with Aura
/
Migraine Disorders
/
Antibodies
Type of study:
Observational study
/
Risk factors
Language:
English
Journal:
Sahel medical journal (Print)
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS